2.200EUR-2.22%Mkt Cap: 131.31M EURP/E: —Last update: 2026-06-01
Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. Its product pipeline includes Midazolam for epileptic seizure; Na…
Industry Peers
Medical Instruments & Supplies146.01BUSDP/E 50.0
86.09BDKKP/E 40.9
79.36BEURP/E 34.8
40.39BUSDP/E 25.6
30.12BUSDP/E 31.2
27.29BUSDP/E 18.1
25.22BCHFP/E 39.2
22.10BUSDP/E 41.8
Indicators:|
Key Statistics
Company
Market Cap131.31M EUR
Enterprise Value136.12M EUR
Revenue (TTM)2.57M EUR
Gross Profit-9.71M EUR
Net Income (TTM)-10.37M EUR
Revenue/Share0.0490 EUR
Last Price2.200 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees99
CountryFR
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)4.33
PEG—
EV/EBITDA-12.78
EV/Revenue53.01
P/S52.30
P/B-24.19
EPS (TTM)-0.19
EPS (Forward)0.52
52W Range
1.34663% of range2.695
52W High2.695 EUR
52W Low1.346 EUR
Profitability
Gross Margin0.00%
Oper. Margin-629.28%
EBITDA Margin0.00%
Profit Margin0.00%
ROE212.74%
ROA-34.07%
Growth
Revenue Growth-59.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.35M EUR
CapEx (TTM)4.50M EUR
FCF Margin-381.37%
FCF Yield-7.46%
Net Debt17.37M EUR
Net Debt/EBITDA-1.63
Balance Sheet
Debt/Equity-4.61
Current Ratio1.53
Quick Ratio1.12
Book Value/Sh-0.0930 EUR
Cash/Share0.0960 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)4.400 EUR
Target Range4.300 EUR – 4.500 EUR
# Analysts2
Ownership
Shares Out.59.69M
Float51.16M
Insiders21.24%
Institutions0.32%
Technical
SMA 502.039 (+7.9%)
SMA 2002.066 (+6.5%)
Beta0.46
S&P 52W Chg27.94%
Avg Vol (30d)445.16K
Avg Vol (10d)728.59K
Technical Indicators
RSI (14)57.8
MACD0.0757
MACD Signal0.0624
MACD Hist.+0.0133
BB Upper2.486 EUR
BB Middle2.100 EUR
BB Lower1.713 EUR
BB Width36.80%
ATR (14)0.1758 EUR
Vol Ratio (20d)1.63x